Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Wuhan Kindstar Diagnostics Raises $11 Million in Series B Funding

publication date: Jun 29, 2011
Wuhan Kindstar Diagnostics, a company that provides esoteric laboratory testing services to China hospitals, raised $11 million in a Series B round. Established in 2003, Kindstar’s network covers 2000 hospitals in 300 China cities, including 660 tertiary care hospitals. The company, which has labs in Beijing, Shanghai and Wuhan, offers 750 advanced diagnostic tests in areas that include hematology, oncology, genetics, infectious diseases, and cardiovascular disease. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital